La Vita Compounding Pharmacy, LLC

Warning LetterClosed

United StatesFEI 3009571102Issued Feb 28, 2019

View FDA's record for FEI 3009571102

Source: FDA warning letter records. FDA has not published the text of this letter. To check it, open FDA's record for this establishment, listed under FEI 3009571102.

Violations0

Issue DateFeb 28, 2019

Product TypeDrugs

StatusClosed

Letter Details

Firm: La Vita Compounding Pharmacy, LLC
Location: United States
FEI Number: 3009571102
Country: United States
Issue Date: February 28, 2019
Issuing Office: N/A
Product Type: Drugs
Status: Closed

Summary

Based on limited metadata, this FDA Warning Letter issued in February 2019 was directed at La Vita Compounding Pharmacy, LLC, a pharmaceutical compounding operation. While the specific violations are not detailed in the available metadata, the warning letter indicates regulatory concerns related to drug manufacturing or compounding practices. The letter falls under FDA's drug product oversight, though the issuing office information is not available in this record.

La Vita Compounding Pharmacy, LLC FDA Warning Letter, February 28, 2019